Kev ua tau zoo thiab kev nyab xeeb ntawm Edoxaban Tosylate Hydrate 15 Mg hauv Kev Tiv Thaiv Venous Thromboembolism hauv cov neeg mob uas muaj lub raum ua haujlwm tsis zoo tom qab kev phais orthopedic ntawm qis qis
Mar 28, 2022
Hu rau: Audrey Hu Whatsapp / hp: 0086 13880143964 Email:audrey.hu@wecistanche.com
Abstract
Keeb kwm:Txawm hais tias tsis tau qhia hauv Tebchaws Meskas, edoxaban tosylate hydrate 15 mg yog siv rau venous thromboembolism (VTE) prophylaxis tom qab orthopedic phais ntawm sab sab hauv Nyiv. Txawm li cas los xij, nws txoj kev ua tau zoo thiab kev nyab xeeb hauv cov neeg mob uas lub raum tsis ua haujlwm tsis tau raug soj ntsuam tag nrho. Peb tsom mus tshawb xyuas qhov kev cuam tshuam cov txiaj ntsig ntawm cov neeg mob no.
Txoj kev:Txij xyoo 2018 txog rau xyoo 2020, cov neeg mob uas tau txais tag nrho lub duav arthroplasty, tag nrho lub hauv caug arthroplasty, kev phais pob txha pob txha, lossis lub hauv caug arthroplasty ib qho granule hloov thiab nrog rau lub raum tsis ua haujlwm raug soj ntsuam. Kev nyab xeeb raug ntsuas raws li qhov tshwm sim los ntshav thaum kho edoxaban thiab lub siab ua haujlwm kawg. Cov neeg mob tau muab faib ua 15- thiab 30-mg pawg ntawm qhov ncauj, suav nrog 23 tus neeg mob lub raum tsis ua haujlwm thiab 209 nrog rau lub raum ua haujlwm, raws li.
Cov txiaj ntsig:VTE tshwm sim hauv {{{0}}} thiab 30-mg pawg yog 8.7 feem pua thiab 8.6 feem pua; qhov sib txawv ntawm pab pawg tsis tseem ceeb (qhov sib txawv ntawm qhov sib txawv [OR] 0.99; 95 feem pua ntawm kev ntseeg siab [CI] 0.22–4.56; p=1.00). Cov ntshav tsis tau tshwm sim hauv pawg 15-mg thiab tau sau tseg hauv 9 cov neeg mob hauv pawg 30-mg thaum kho nrog edoxaban; qhov sib txawv ntawm pab pawg tsis tseem ceeb (p=1 00). Qhov nce hauv aspartate aminotransferase thiab alanine aminotransferase qib yog 30 feem pua ntawm cov pab pawg 15-mg thiab 19 feem pua hauv pawg 30-mg, tsis muaj qhov sib txawv ntawm cov pab pawg (p=0.27) . Kev txheeb xyuas ntau yam tau pom tias koob tshuaj edoxaban tsis yog qhov tseem ceeb cuam tshuam nrog qhov tshwm sim ntawm VTE (hloov OR 2.31; 95 feem pua CI 0.39–13.8; p=0.36).
Cov lus xaus:Edoxaban 15 mg rau cov neeg mob uas lub raum tsis ua haujlwm tuaj yeem ua haujlwm zoo li edoxaban 30 mg rau cov neeg mob uas lub raum ua haujlwm. Txawm li cas los xij, tus lej ntawm cov xwm txheej suav nrog hauv qhov kev tshawb fawb no tsawg thiab lub zog tsis txaus; yog li ntawd, ib qho kev kawm nrog ib qho piv txwv loj dua yog qhov xav tau.
Ntsiab lus:Edoxaban tosylate, Heparin, Deep vein thrombosis, Arthroplasty, Pulmonary thromboembolism

Cistanche deserticola extract: tiv thaiv kab mob raum
Keeb kwm
Kev sib sib zog nqus venous thrombosis (DVT) yog ib qho teeb meem loj uas tuaj yeem txhim kho tom qab phais orthopedic, thiab qee zaus, nws tuaj yeem ua rau tuag taus pulmonary thromboembolism (PTE). Yog li ntawd, kev tiv thaiv DVT tseem ceeb heev. Hauv orthopedics, cov xwm txheej ntawm tag nrho lub hauv caug arthroplasty (THA), tag nrho lub hauv caug arthroplasty (TKA), unicompartmental lub hauv caug arthroplasty (UKA), thiab kev phais pob txha pob txha (HFS) rau kev tswj cov pob txha pob txha yog nce ntxiv nrog cov laus ntawm cov pejxeem. Tag nrho cov kev phais no raug cais raws li cov txheej txheem uas muaj kev pheej hmoo siab ntawm venous thromboembolism (VTE) [1].
Conventionally, low-molecular-weight heparin thiab unfractionated heparin tau siv raws li cov qauv tshuaj rau VTE prophylaxis tom qab phais orthopedic ntawm qis extremities. Txawm li cas los xij, kev tswj hwm cov tshuaj no nyuaj vim tias lawv yog cov tshuaj txhaj. Hauv Nyij Pooj, dabigatran, apixaban, thiab rivaroxaban tsis tau qhia txog kev tiv thaiv VTE tom qab kev phais orthopedic qis. Edoxaban tosylate hydrate (edoxaban) tau tsim tawm hauv xyoo 2011 thiab yog tib lub qhov ncauj ncaj qha tshuaj tiv thaiv kab mob rau VTE tiv thaiv tom qab qis qis qis orthopedic phais hauv Nyiv. Txawm hais tias edoxaban 30 mg / hnub feem ntau yog siv rau VTE prophylaxis tom qab phais orthopedic ntawm qis extremities, lub pob ntxig hauv Nyiv hais tias, "Hauv cov neeg mob uas muaj creatinine clearance (Ccr) ntawm 30 mL / min lossis ntau dua tab sis tsawg dua 50 mL / min. Cov koob tshuaj yuav tsum raug txo mus rau 15 mg ib hnub ib zaug tom qab soj ntsuam txhua tus neeg mob qhov kev pheej hmoo ntawm kev tsim cov hlab ntsha venous thiab los ntshav. " Txawm li cas los xij, hauv STARS-JV thiab STARS-E3 cov kev tshawb fawb [2, 3], theem III kev sim ntawm edoxaban hauv cov neeg mob uas tau teem caij mus rau THA thiab TKA, raws li, edoxaban 15 mg tsis muaj txiaj ntsig, thiab nws qhov kev kho mob tsis tuaj yeem lees paub.
Ntau qhov kev tshawb fawb tau ntsuas qhov ua tau zoo ntawm edoxaban 15 mg rau cov neeg mob uas lub raum ua haujlwm tsis zoo [4, 5]. Txawm li cas los xij, rau peb txoj kev paub, tsis muaj kev tshawb fawb tau soj ntsuam nws qhov ua tau zoo hauv cov neeg mob uas txo lub raum ua haujlwm. Yog li, hauv txoj kev tshawb no, peb tau tshawb xyuas qhov ua tau zoo thiab kev nyab xeeb ntawm edoxaban 15 mg rau kev tiv thaiv VTE tom qab phais orthopedic ntawm cov ceg qis hauv cov neeg mob uas lub raum tsis ua haujlwm.

cistanche hmoov: kho kab mob raum
Cov txheej txheem
Hom neeg mob
Cov neeg mob uas tau txais THA, TKA, HFS, lossis UKA thaum Lub Ib Hlis 1, 2018, thiab Kaum Ob Hlis 31, 2020, ntawm Lub Tsev Haujlwm Saib Xyuas Kev Khomob ntawm Kariya Toyota General Tsev Kho Mob (txog li no hu ua "peb tsev kho mob") tau txiav txim siab. Ntawm cov neeg mob no, cov neeg uas muaj 30 mL / min Tsawg dua lossis sib npaug Ccr< 50="" ml/min="" and="" who="" received="" edoxaban="" 15="" mg,="" and="" those="" with="" 50="" ml/min="" ≤="" ccr="" and="" who="" received="" edoxaban="" 30="" mg="" for="" vte="" prophylaxis="" were="" included="" in="" the="" study.="" patients="" with="" ccr="" <="" 30="" ml/min="" or="" who="" did="" not="" use="" edoxaban="" with="" preoperative="" dvt="" or="" with="" unknown="" dvt="" were="">
Txoj kev tshawb nrhiav
Qhov kev tshawb nrhiav rov qab no tau ua los ntawm kev siv cov ntaub ntawv kho mob hluav taws xob. Cov ntaub ntawv rau cov yam ntxwv hauv qab no tau sau tseg: hnub nyoog, poj niam txiv neej, qhov hnyav, lub cev qhov hnyav, lub raum ua haujlwm, keeb kwm kho mob, thiab cov tshuaj sib xyaw ua ke. Lub tsheb raug suav nrog Cockcroft– Gault kab zauv: Ccr (mL/min) {{0}} (140–age) × nyhav/ (72 × serum creatinine nqi); rau cov poj niam cov neeg mob, tus nqi tau muab faib ua 0.85. Tsis tas li ntawd, keeb kwm ntawm intracranial hemorrhage, stroke, gastrointestinal los ntshav, VTE, thiab malignancy tau tshawb xyuas.
Cov tshuaj sib xyaw ua ke uas tau noj suav nrog P-glycoprotein inhibitors (quinidine sulfate hydrate, verapamil hydrochloride, erythromycin, cyclosporine, azithromycin, clarithromycin, itraconazole, diltiazem, amiodarone hydrochloride, thiab HIV protease inhibitors), antiplatelet alkaloids, , clopidogrel, prasugrel hydrochloride, ticagrelor, thiab cilostazol), HMG-CoA reductase inhibitors, cov tshuaj estrogen tsawg, xaiv cov tshuaj estrogen receptor modulators (raloxifene hydrochloride thiab acetate), corticosteroids, tranexamic acid, tshuaj tiv thaiv kev mob ntshav siab, inhibitors, noradrenergic thiab tshwj xeeb serotonergic antidepressants, tricyclic antidepressants, tetracyclic antidepressants, thiab lithium carbonate), thiab antipsychotics (phenothiazine, butyrophenones, benzamides, serotonin-dopamine antagonists, multi-acting psychic-targeted receptors).
Kev ua tau zoo tau raug soj ntsuam los ntawm qhov tshwm sim ntawm VTE tshiab rau hnub tom qab kev phais hnub 7 raws li kev txo qis qis ntawm ultrasonography. Kev nyab xeeb raug soj ntsuam raws li qhov muaj lossis tsis muaj los ntshav thaum kho edoxaban thiab lub siab ua haujlwm kawg. Hais txog qhov tshwm sim ntawm cov xwm txheej hemorrhagic, cov ntaub ntawv hais txog los ntshav tau muab rho tawm los ntawm cov ntaub ntawv kho mob hluav taws xob.
Cov ntshav tau muab faib ua cov ntshav loj, cov kev kho mob uas tsis yog qhov tseem ceeb (CRNM) los ntshav, thiab cov ntshav me me, nrog rau cov ntshav loj, tau lees paub raws li International Society on Thrombosis thiab Hemostasis cov txheej txheem [6]. CRNM los ntshav tau txhais tau tias los ntshav uas tsis ua raws li cov txheej txheem los ntshav loj tab sis cuam tshuam nrog hematoma (tsawg kawg 5 cm ntawm qhov ntev), ntshav ntswg, lossis gingival los ntshav (tsawg kawg 5 feeb), los ntshav hauv plab, lossis tag nrho hematuria ( tsis tu ncua tom qab 24 teev), los yog los ntshav ntsuas raws li kev kho mob tseem ceeb. Hais txog kev los ntshav me, tag nrho lwm yam kev tshwm sim los ntshav, suav nrog microscopic hematuria, uas tsis tau cais raws li qhov loj lossis CRNM los ntshav, raug txiav txim siab. Cov ntsiab lus ntawm lub siab ua haujlwm tau raug tshawb xyuas los ntawm kev txiav txim siab aspartate aminotransferase (AST) thiab alanine aminotransferase (ALT) qib los ntawm kev kuaj ntshav rau hnub tom qab kev phais hnub 10 los xyuas seb lawv puas siab tshaj 1.5- lossis peb npaug ntawm cov qauv hauv tsev.

cistanche tshuaj ntsuab
Qauv loj
Txhawm rau txheeb xyuas qhov sib txawv ntawm 17 feem pua ntawm qhov tshwm sim ntawm VTE ntawm edoxaban 15- thiab 30-mg pawg, ib qho piv txwv loj ntawm 132 tus neeg mob (66 hauv txhua pab pawg) tau kwv yees kom ua tiav lub zog ntawm 8{ {19}} feem pua raws li kev kwv yees ntawm 3 feem pua thiab 20 feem pua kev pheej hmoo ntawm VTE hauv edoxaban 30- thiab 15-mg pawg, raws li. Qhov tshwm sim ntawm VTE hauv cov neeg mob uas tau txais edoxaban 30 mg yog kwv yees los ntawm tsab ntawv tshaj tawm dhau los [3]. Qhov tshwm sim ntawm VTE hauv cov neeg mob uas muaj lub raum tsis ua haujlwm uas tau txais edoxaban 15 mg tau kwv yees kwv yees li 20 feem pua , cia siab tias yuav muaj txiaj ntsig zoo ib yam li edoxaban 30 mg rau cov neeg mob uas lub raum ua haujlwm tsis zoo, uas tau tshaj tawm yav dhau los [5 ]. Kev pheej hmoo ntawm VTE thaum tsis muaj thromboprophylaxis tom qab phais orthopedic nws txawv; Txawm li cas los xij, nws tau tshaj tawm tias yog 60-70 feem pua hauv kev tshawb fawb dhau los ua rau cov neeg mob Asian [7]. Hom kuv yuam kev ( ) yog 0.05.
Cov txheej txheem txheeb cais
EZR version 1.54 (Jichi Medical University Saitama Medical Center, Nyiv) tau siv rau kev txheeb cais [8]. Mann–Whitney U test thiab Student's t-test tau siv los sib piv qhov sib txawv tsis tu ncua tom qab lees paub qhov qub thiab faib cov ntaub ntawv rau kev sib piv ob pawg, raws li qhov tsim nyog. Fisher qhov kev ntsuas tseeb tau siv los sib piv cov nominal variables. Statistical tseem ceeb tau teeb tsa ntawm p<0.05. multivariate="" analysis="" was="" performed="" using="" a="" logistic="" regression="">0.05.>
Kev hloov kho rau tus neeg mob keeb kwm yav dhau tus yam ntxwv
Txhua qhov sib txawv tseem ceeb hauv cov neeg mob cov yam ntxwv keeb kwm yav dhau los ntawm ob pawg tau raug kho los ntawm kev txheeb xyuas ntau yam.
Kev xav txog kev ncaj ncees
Txoj kev tshawb no tau ua raws li Kev Tshaj Tawm ntawm Helsinki 1964 thiab ib qho kev hloov kho tom ntej "Cov Lus Qhia Txog Kev Kho Mob thiab Kev Tshawb Fawb Txog Kev Noj Qab Haus Huv Txog Tib Neeg," thiab "Cov Lus Qhia rau Kev Tswj Xyuas Tus Kheej Cov Ntaub Ntawv rau Cov Kws Kho Mob thiab Cov Kws Kho Mob." Kev pom zoo tau txais los ntawm lub tsev kho mob pawg saib xyuas kev coj ncaj ncees, thiab kev txiav txim siab tsim nyog tau muab rau kev tiv thaiv tus kheej cov ntaub ntawv (kev pom zoo no. 577).

cistanche tshuaj xyuas: anti-aging
Cov txiaj ntsig
Cov yam ntxwv ntawm tus neeg mob
Daim ntawv qhia txog cov neeg mob suav nrog rau txoj kev tshawb fawb tau pom nyob rau hauv daim duab 1, thiab cov neeg mob cov ntaub ntawv keeb kwm yav dhau tau qhia hauv Table 1. Cov pab pawg 15-mg muaj 23 cov neeg mob uas lub raum tsis ua haujlwm, thiab 30-mg pab pawg ntawm qhov ncauj muaj 209 tus neeg mob uas muaj lub raum ua haujlwm. Te Ccr ntawm 15-mg pawg tau qis dua li ntawm 30-mg pawg; Tsis tas li ntawd, cov neeg mob hauv 15-mg pawg kuj tseem muaj hnub nyoog ntau dua li cov hauv pawg 30-mg. Txawm li cas los xij, kev sib txawv ntawm pab pawg hauv lwm cov yam ntxwv keeb kwm yav dhau tsis tseem ceeb.

Kev kho mob tshwm sim
Table 2 qhia qhov tshwm sim ntawm VTE hauv ob pawg. Qhov tshwm sim ntawm VTE hauv 15- thiab 30-mg pawg yog 8.7 feem pua (2/23 cov neeg mob) thiab 8.6 feem pua (18/209 cov neeg mob), feem, thiab tsis muaj tseem ceeb sib txawv ntawm cov pab pawg. Tsis tas li ntawd, txhua tus neeg mob VTE cuam tshuam nrog cov neeg mob uas muaj DVT (p=1 00). Tom qab kho qhov sib txawv tseem ceeb hauv cov neeg mob cov yam ntxwv keeb kwm yav dhau los ntawm ob pawg (hnub nyoog [nruam hloov pauv], lub raum ua haujlwm [nruam hloov pauv], thiab koob tshuaj edoxaban [15 mg lossis 30 mg]), qhov tshwm sim ntawm VTE nce 1.{{16 }}fold nrog txhua xyoo ntxiv ntawm hnub nyoog (hloov OR 1.07; 95 feem pua CI 1.00–1.15, p= 0.05) thiab cov koob tshuaj edoxaban tau pom tias tsis yog qhov tseem ceeb cuam tshuam nrog qhov xwm txheej ntawm VTE (hloov OR 2.31; 95 feem pua CI 0.39–13.8, p= 0.36) (Table 3).
Table 4 qhia cov ntaub ntawv ntawm qhov muaj ntshav thiab AST/ALT nce raws li kev ntsuas kev nyab xeeb. Txawm hais tias cuaj tus neeg mob hauv 30-mg pab pawg tau ntsib los ntshav thaum noj edoxaban, los ntshav me me hauv txhua kis, thiab qhov sib txawv ntawm pawg tsis tseem ceeb. Tsis tas li ntawd, tsis muaj qhov sib txawv ntawm qhov nce ntawm AST thiab ALT theem ntawm cov pab pawg.

Kev sib tham
Hauv txoj kev tshawb no, peb tau muab piv rau kev ua tau zoo thiab kev nyab xeeb ntawm VTE prophylaxis tom qab kev phais orthopedic ntawm qis extremities hauv ob pawg: edoxaban 15-mg pab pawg nrog rau lub raum tsis ua haujlwm thiab edoxaban 30-mg pab pawg ntawm qhov ncauj nrog normalize lub raum ua haujlwm. Qhov kev sib piv yog raws li VTE tshwm sim, los ntshav, thiab lub siab ua haujlwm tsis zoo. Txawm li cas los xij, tsis muaj qhov sib txawv tseem ceeb ntawm cov pab pawg nyob rau hauv cov nqe lus ntawm ib qho ntawm cov khoom ntsuas. Kwv yees li 50 feem pua ntawm edoxaban raug tso tawm los ntawm ob lub raum [9], thiab lub cev hnyav thiab lub raum ua haujlwm tau raug tshaj tawm tias yog yam uas ua rau muaj tshuaj ntau ntxiv [10]. Tsis tas li ntawd, cov tshuaj pharmacokinetics ntawm cov tshuaj yog linear [9], thiab qhov tseem ceeb Xa (FXa) kev ua haujlwm, uas tau tshaj tawm tias yog ib qho cim ntawm anticoagulant muaj peev xwm los ntawm cov ntshav coagulation FXa inhibitors, tau raug pom zoo kom ua proportional rau cov ntshav concentration ntawm cov tshuaj. FXa inhibitor [11, 12].
Cov kev tshawb fawb yav dhau los [4, 5] tshuaj xyuas qhov xav tau koob tshuaj edoxaban rau VTE prophylaxis qhia tias qhov koob tshuaj ntau dua, qhov tshwm sim ntawm VTE qis dua. Nws kuj tau pom tias qhov tshwm sim ntawm VTE txo qis nrog kev nce ntxiv ntawm cov tshuaj FXa inhibitors xws li apixaban thiab rivaroxaban [13–15]. Cov txiaj ntsig no qhia tias FXa inhibitors tsis ua rau cov tshuaj tiv thaiv coagulant tshwj tsis yog tias cov ntshav txaus ua tiav. Tsis tas li ntawd, nws tau raug tshaj tawm tias kev tswj hwm ntawm 15 mg edoxaban rau cov neeg mob uas lub raum tsis ua haujlwm tau ua rau tib cov ntshav concentration raws li qhov ua tiav nrog 30 mg edoxaban thaum muab rau cov neeg mob uas lub raum ua haujlwm [16, 17]. Thaum siv rau atrial fibrillation, txawm tias ib koob tshuaj 15 mg edoxaban zoo rau cov neeg laus [18]. Hauv kev tshawb fawb tam sim no, pawg 15-mg tau laus dua thiab muaj Ccr qis dua li pawg 30-mg, qhia tias ob pawg muaj cov ntshav zoo sib xws ntawm edoxaban. Kev txheeb xyuas ntau yam hauv qhov kev tshawb fawb no tau pom tias muaj hnub nyoog laus yog qhov muaj feem pheej hmoo rau VTE. Txawm hais tias pawg 15-mg muaj qhov pheej hmoo ntawm VTE ntau dua li cov pab pawg 30-mg, cov ntshav zoo sib xws tau txais hauv ob pawg, uas tej zaum yuav yog ib qho laj thawj rau qhov zoo sib xws ntawm qhov tshwm sim ntawm VTE.
Hais txog kev ntsuas kev nyab xeeb, tsis muaj qhov sib txawv tseem ceeb hauv qib AST thiab ALT, uas yog siv los ua cov cim ntawm daim siab puas tsuaj, ntawm cov pab pawg. Hepatotoxicity tshwm sim los ntawm heparin (heparin yog ib txwm siv rau VTE prophylaxis) yog suav tias yog ncua sij hawm thiab thim rov qab [19] thiab tsis tshua muaj teeb meem loj. Edoxaban cuam tshuam nrog kev pheej hmoo ntawm hepatotoxicity tsawg dua li heparin [20], thiab hauv peb txoj kev kho mob, lub sijhawm kho edoxaban tsuas yog 10 hnub xwb. Yog li ntawd, cov nyhuv ntawm hepatotoxicity tau suav tias yog me me. Hais txog los ntshav, tsis muaj los ntshav loj lossis CRNM los ntshav tshwm sim hauv ob pawg. Plaub tus neeg mob hauv 30-mg pab pawg ntawm qhov ncauj nthuav tawm los ntshav me thiab tuaj yeem noj tshuaj ntxiv.

standardized cistanche: tiv thaiv kab mob
Hauv kev tshawb fawb tam sim no, pawg 15-mg tau laus dua thiab muaj lub raum tsis zoo dua li cov pawg 30-mg. Qhov kev pheej hmoo ntawm cov ntshav los tiv thaiv coagulant yog siab dua hauv cov neeg mob laus [21], thiab txo qis raum ua haujlwm cuam tshuam nrog kev pheej hmoo ntawm kev tsim VTE thiab los ntshav [22, 23]. Nws tau raug pom zoo tias cov ntshav siab ntawm FXa inhibitors pab txhawb kom los ntshav ntau ntxiv [24], thiab txo cov koob tshuaj edoxaban rau 15 mg los tiv thaiv kev nce ntshav ntau dhau tuaj yeem txo qhov tshwm sim los ntshav. Feem ntau, edoxaban yog siv rau lub sijhawm luv luv (10-14 hnub) tom qab kev phais orthopedic ntawm qis qis, thiab VTE feem ntau tshwm sim nyob rau hauv thaum ntxov postoperative lub sij hawm [1]. Yog li ntawd, nws yog ib qho tsim nyog kom tsis txhob noj edoxaban koob tshuaj txo qis raws li qhov poob phaus uas tsis ua raws li qhov hnyav thiab txo lub raum ua haujlwm. Txawm li cas los xij, nws kuj tau taw qhia tias kev noj tshuaj ntau dhau ntawm cov tshuaj tiv thaiv coagulants tuaj yeem ua rau muaj kev pheej hmoo los ntshav loj [25]. Hais txog kev ua tau zoo thiab kev nyab xeeb, edoxaban 15 mg yuav tsum yog qhov kev xaiv muaj txiaj ntsig rau kev tiv thaiv VTE tom qab phais orthopedic ntawm cov ceg qis hauv cov neeg mob uas lub raum tsis ua haujlwm.
Txoj kev tshawb no muaj qee qhov kev txwv. Kev noj tshuaj ntawm cov ntawv sau npe tau tshwm sim nyob rau ntau qhov xwm txheej, thiab tsis txaus cov neeg mob uas txo lub raum ua haujlwm tuaj yeem suav nrog (cov qauv tsis txaus). Tsis tas li ntawd, qhov no yog ib qho kev soj ntsuam xyuas rov qab, thiab peb tsis muaj cov ncauj lus kom ntxaws xws li qib kev ua haujlwm ua ntej nkag mus, siv lub twj tso kua mis taw, thiab lub sijhawm pib ntawm kev rov ua haujlwm tom qab; kev suav ntawm lub raum ua haujlwm yam tsis muaj kev kho rau qib creatinine hauv cov neeg laus thiab cov neeg mob hnyav; thiab kev ntsuam xyuas ntawm thrombus hnub tom qab kev phais 7 thiab tsis tom qab ntawd. Lwm qhov kev txwv ntawm txoj kev tshawb no yog tias cov placebo tsis tau siv rau hauv pab pawg neeg lub hom phiaj thiab qhov tseem ceeb Xa concentration tsis tau ntsuas los kwv yees cov nyhuv tshuaj.
Txawm hais tias causality tsis tau tshawb xyuas tag nrho, tsis muaj qhov sib txawv ntawm qhov ua tau zoo thiab kev nyab xeeb ntawm edoxaban tosylate 15 mg hauv cov neeg mob uas lub raum tsis ua haujlwm piv nrog cov edoxaban tosylate 30 mg hauv cov neeg mob uas lub raum ua haujlwm. Yog li ntawd, edoxaban 15 mg tej zaum yuav yog ib qho kev xaiv rau cov neeg mob uas txo lub raum ua haujlwm thiab yuav tsum tau kuaj ntawm qhov loj dua.

Cov lus xaus
Peb cov txiaj ntsig tau qhia tias edoxaban tosylate 15 mg yog qhov kev xaiv zoo rau kev tiv thaiv VTE tom qab kev phais orthopedic ntawm qis qis hauv cov neeg mob uas lub raum tsis ua haujlwm; Txawm li cas los xij, peb qhov kev tshawb pom yuav tsum raug lees paub hauv kev tshawb fawb loj dua.
Kev siv
1. Falck-Letter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, et al. Kev Tiv Thaiv VTE hauv cov neeg mob phais orthopedic: kev kho mob antithrombotic thiab kev tiv thaiv ntawm thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Lub hauv siab. 2012;141:e278S-325S.
2. Fuji T, Wang CJ, Fujita S, Kawai Y, Nakamura M, Kimura T, et al. Kev nyab xeeb thiab kev ua tau zoo ntawm edoxaban, qhov ncauj qhov ncauj Xa inhibitor, piv rau enoxaparin rau thromboprophylaxis tom qab tag nrho lub hauv caug arthroplasty: STARS E-3 sim. Thromb Res. 2014; 134: 1198–204.
3. Fuji T, Fujita S, Kawai Y, Nakamura M, Kimura T, Fukuzawa M, et al. Kev ua tau zoo thiab kev nyab xeeb ntawm edoxaban piv rau enoxaparin rau kev tiv thaiv ntawm venous thromboembolism tom qab tag nrho cov hip arthroplasty: STARS JV. Thromb J. 2015; 13:27.
4. Fuji T, Fujita S, Tachibana S, Kawai Y. Kev tshawb fawb ntau npaum li cas los ntsuas qhov ncauj qhov ncauj Xa inhibitor edoxaban rau kev tiv thaiv ntawm venous thromboembolism hauv cov neeg mob uas tau txais tag nrho lub hauv caug arthroplasty. J Thromb Haemost. 2010; 8:2458–68.
5. Raskob G, Cohen AT, Eriksson BI, Puskas D, Shi M, Bocanegra T, et al. Qhov ncauj ncaj qha cuam tshuam Xa inhibition nrog edoxaban rau thromboprophylaxis tom qab xaiv tag nrho lub duav hloov. Ib qho kev tshawb fawb randomized ob qhov muag tsis pom kev tshuaj- teb. Thromb Haemost. 2010; 104:642–9.
6. Schulman S, Kearon C. Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Lub ntsiab lus ntawm cov ntshav loj hauv kev tshawb fawb soj ntsuam ntawm cov tshuaj tiv thaiv hemostatic hauv cov neeg mob uas tsis yog phais. J Thromb Haemost. 2005; 3:692–4.
7. Dhillon KS, Iskander A, Doraismay S. Postoperative deep-vein thrombosis hauv cov neeg Esxias tsis yog qhov tsis tshua muaj: kev kawm yav tom ntej ntawm 88 tus neeg mob uas tsis muaj kev tiv thaiv. J Pob txha Joint Surg Br. 1996; 78:427–30.
8. Kanda Y. Kev soj ntsuam ntawm cov dawb-rau-siv software 'EZR' rau cov ntaub ntawv kho mob. Pob txha pob txha Transplant. 2013; 48:452–8.
9. Ogata K, Mendell-Harary J, Tachibana M, Masumoto H, Oguma T, Kojima M, et al. Clinical kev nyab xeeb, kam rau ua, pharmacokinetics, thiab pharmacodynamics ntawm qhov tshiab yam Xa inhibitor edoxaban hauv cov neeg ua haujlwm noj qab haus huv. J Clin Pharmacol. 2010; 50:743–53.
10. Salazar DE, Mendell J, Kastrissios H, Green M, Carrothers TJ, Song S, et al. Ua qauv thiab simulation ntawm edoxaban raug thiab teb kev sib raug zoo hauv cov neeg mob atrial fibrillation. Thromb Haemost. 2012; 107:925–36.
11. Kreutz R, Persson PB, Kubitza D, Thelen K, Heitmeier S, Schwers S, et al. Dissociation ntawm pharmacokinetics thiab pharmacodynamics ntawm ib hnub ib zaug rivaroxaban thiab ob zaug-ib hnub apixaban: ib tug randomized crossover txoj kev kawm. J Thromb Haemost. Xyoo 2017; 15: 2017-28.
12. Yin QOP, Antman EM, Braunwald E, Mercuri MF, Miller R, Morrow D, et al. Txuas endogenous yam Xa kev ua haujlwm, ib qho khoom siv tshuaj lom neeg muaj txiaj ntsig, rau edoxaban plasma concentrations thiab cov txiaj ntsig kev kho mob hauv ENGAGE AF-TIMI 48 sim. Kev ncig. 2018; 138: 1963–73.
13. Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, et al. Ib zaug ib hnub, qhov ncauj, ncaj qha cuam tshuam Xa inhibitor, rivaroxaban (BAY 59–7939), rau thromboprophylaxis tom qab tag nrho lub duav hloov. Kev ncig. 2006; 114: 2374–81.
14. Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, et al. Dose- escalation kawm ntawm rivaroxaban (BAY 59–7939) - qhov ncauj, ncaj qha Xa inhibitor - rau kev tiv thaiv ntawm venous thromboembolism nyob rau hauv cov neeg mob hloov tag nrho lub duav. Thromb Res. 2007; 120:685–93.
15. Lassen MR, Davidson BL, Gallus A, Pineo G, Ansell J, Deitchman D. Kev ua tau zoo thiab kev nyab xeeb ntawm apixaban, qhov ncauj, qhov ncaj qha Xa inhibitor, raws li thromboprophylaxis hauv cov neeg mob tom qab tag nrho lub hauv caug hloov. J Thromb Haemost. 2007; 5:2368–75.
16. Koretsune Y, Yamashita T, Kimura T, Fukuzawa M, Abe K, Yasaka M. Kev nyab xeeb luv luv thiab plasma concentrations ntawm edoxaban nyob rau hauv Nyiv cov neeg mob uas tsis yog-valvular atrial fibrillation thiab mob raum tsis zoo. Circ J. 2015; 79:1486–95.
17. Shimizu T, Tachibana M, Kimura T, Kumakura T, Yoshihara K. Population pharmacokinetics ntawm edoxaban nyob rau hauv Japanese atrial fibrillation cov neeg mob uas mob raum tsis zoo. Clin Pharmacol Drug Dev. 2017; 6:484–91.
18. Okumura K, Akao M, Yoshida T, Kawata M, Okazaki O, Akashi S, et al. Tsawg koob tshuaj edoxaban hauv cov neeg laus heev uas muaj atrial fibrillation. N Engl J Med. 2020; 383: 1735–45.
19. Carlson MK, Gleason PP, Sen S. Kev nce siab ntawm hepatic transaminases tom qab siv enoxaparin: cov ntaub ntawv qhia thiab tshuaj xyuas ntawm cov tsis muaj zog thiab qis molecular-yuag heparin-induced hepatotoxicity. Pharmacotherapy. 2001; 21:108–13.
20. Caldeira D, Barra M, Santos AT, de Abreu D, Pinto FJ, Ferreira JJ, et al. Kev pheej hmoo ntawm kev raug mob rau lub siab nrog cov tshuaj tiv thaiv kab mob hauv qhov ncauj tshiab: kev tshuaj xyuas thiab kev tshuaj xyuas meta. Lub plawv. 2014; 100:550–6.






